Stabilizing effect of colicin E2 on the "spheroplast membrane".

Area of Science:

• Microbiology
• Molecular Biology
• Cell Biology

Background:

• Colicins are bacteriocins produced by Escherichia coli that exhibit antimicrobial activity.
• Colicin E2 is known to induce DNA cleavage in sensitive cells.
• Spheroplasts are bacterial cells that have had their cell walls removed, making them osmotically sensitive.

Purpose of the Study:

• To investigate the effect of colicin E2 treatment on the stability of Escherichia coli spheroplasts.
• To determine the conditions and reversibility of any observed stabilization.
• To explore potential mechanisms underlying the observed changes in spheroplast stability.

Main Methods:

• Escherichia coli W3110 and its thymineless mutant were treated with colicin E2.
• Treated and untreated cells were converted to spheroplasts.
• Spheroplast stability was assessed by measuring turbidity reduction upon incubation with ethylenediaminetetraacetic acid-lysozyme.
• Inhibitory effects of 2,4-dinitrophenol and streptomycin were evaluated.
• Cells harboring the colicin E2 factor were also tested.

Main Results:

• Spheroplasts derived from colicin E2-treated cells exhibited enhanced stability compared to those from untreated cells.
• Untreated spheroplasts showed a 45% reduction in turbidity, while colicin E2-treated spheroplasts showed only a 25% reduction.
• The stabilization effect was irreversible and required 5 minutes of colicin E2 treatment at 37°C.
• The stabilization process was inhibited by 2,4-dinitrophenol and streptomycin.
• Cells containing the colicin E2 factor were unaffected by colicin E2 treatment.
• No alterations in phospholipid composition were observed.

Conclusions:

• Colicin E2 treatment induces an irreversible stabilization of Escherichia coli spheroplasts.
• This stabilization is likely an energy-dependent process, as indicated by inhibition with 2,4-dinitrophenol and streptomycin.
• The mechanism of stabilization does not involve changes in phospholipid composition.
• Colicin E2 resistance in cells harboring the colicin E2 factor suggests a different interaction or protective mechanism.